Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.
Lindner S, Dahlke K, Sontheimer K, Hagn M, Kaltenmeier C, Barth TF, Beyer T, Reister F, Fabricius D, Lotfi R, Lunov O, Nienhaus GU, Simmet T, Kreienberg R, Möller P, Schrezenmeier H, Jahrsdörfer B. Lindner S, et al. Among authors: jahrsdorfer b. Cancer Res. 2013 Apr 15;73(8):2468-79. doi: 10.1158/0008-5472.CAN-12-3450. Epub 2013 Feb 5. Cancer Res. 2013. PMID: 23384943
S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10+/IDO+ lymphocytes.
Eisenbacher JL, Schrezenmeier H, Jahrsdörfer B, Kaltenmeier C, Rojewski MT, Yildiz T, Beyer T, Erle A, Wiegmann DS, Grassl S, Hang R, Körper S, Wiesneth M, Lotze MT, Lotfi R. Eisenbacher JL, et al. Among authors: jahrsdorfer b. J Immunol. 2014 Jun 15;192(12):6102-10. doi: 10.4049/jimmunol.1303144. Epub 2014 May 2. J Immunol. 2014. PMID: 24795458 Clinical Trial.
CD4+ T cell-derived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme B-expressing regulatory B cells in HIV patients.
Kaltenmeier C, Gawanbacht A, Beyer T, Lindner S, Trzaska T, van der Merwe JA, Härter G, Grüner B, Fabricius D, Lotfi R, Schwarz K, Schütz C, Hönig M, Schulz A, Kern P, Bommer M, Schrezenmeier H, Kirchhoff F, Jahrsdörfer B. Kaltenmeier C, et al. Among authors: jahrsdorfer b. J Immunol. 2015 Apr 15;194(8):3768-77. doi: 10.4049/jimmunol.1402568. Epub 2015 Mar 16. J Immunol. 2015. PMID: 25780036
An enzyme-based immunodetection assay to quantify SARS-CoV-2 infection.
Conzelmann C, Gilg A, Groß R, Schütz D, Preising N, Ständker L, Jahrsdörfer B, Schrezenmeier H, Sparrer KMJ, Stamminger T, Stenger S, Münch J, Müller JA. Conzelmann C, et al. Among authors: jahrsdorfer b. Antiviral Res. 2020 Sep;181:104882. doi: 10.1016/j.antiviral.2020.104882. Epub 2020 Jul 29. Antiviral Res. 2020. PMID: 32738255 Free PMC article.
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
Hoffmann M, Arora P, Groß R, Seidel A, Hörnich BF, Hahn AS, Krüger N, Graichen L, Hofmann-Winkler H, Kempf A, Winkler MS, Schulz S, Jäck HM, Jahrsdörfer B, Schrezenmeier H, Müller M, Kleger A, Münch J, Pöhlmann S. Hoffmann M, et al. Among authors: jahrsdorfer b. Cell. 2021 Apr 29;184(9):2384-2393.e12. doi: 10.1016/j.cell.2021.03.036. Epub 2021 Mar 20. Cell. 2021. PMID: 33794143 Free PMC article.
70 results